Assessment first
Your medical history, current medicines, examination and relevant investigations should inform every treatment decision.
Clinical supply. Medical governance.
Precision belongs in medical hands.
NOVATHERIS is a professional therapeutic brand centred on peptide-based and co-enzyme therapies. Access is practitioner-led, product-specific and subject to South African legal and regulatory requirements.
Doctor-ledAssessment before therapy
Prescription-onlyWhere scheduling requires it
TraceableBatch and label-led reporting
MonitoredClinical follow-up matters
For patients
Confidence without overclaiming.
NOVATHERIS products are not intended for self-selection or casual “wellness” use. Your treating practitioner must decide whether a particular therapy is lawful, clinically appropriate and suitable for you.
Informed consent
Your practitioner should explain the product’s regulatory status, expected role, material risks, alternatives, costs and the option to decline.
Clinical follow-up
Therapy should be reviewed against agreed clinical goals. New symptoms or concerns belong with your treating practitioner—not an internet protocol.
The therapeutic field
Biology is nuanced. Treatment should be too.
The words “peptide” and “co-enzyme” describe broad scientific categories—not proof that every substance is safe, effective, registered or appropriate for every patient.
Peptides
Peptides are short chains of amino acids. Some act as signalling molecules in human biology; others have no established therapeutic role. Clinical evidence and regulatory status differ substantially between individual molecules.
Co-enzymes
Co-enzymes participate in biochemical reactions. NAD is one example involved in cellular metabolism. That biological role does not, by itself, establish a clinical indication, route, dose or benefit.
Individualised medicine
Appropriate use depends on the patient, the evidence, the product’s legal status and the prescriber’s professional judgement. Brand information never replaces product-specific prescribing information.
The NOVATHERIS framework
Designed for accountable care.
The platform is structured around professional verification, product-specific documentation, traceability and a defined route for safety or quality concerns.
Practitioner verification
Professional access is reviewed against current HPCSA registration and practice details. Approval is not automatic and does not extend anyone’s legal scope of practice.
Product-specific documentation
Applicable prescribing, storage, handling and regulatory information must accompany the particular product and lawful supply route. A generic website cannot replace it.
Traceability
Labels should identify the product, batch or lot and expiry details so that a concern can be investigated through the relevant supply chain.
Responsible reporting
Patients and practitioners can submit product safety, quality or effectiveness concerns through the QR-linked reporting route for follow-up and onward regulatory reporting where required.
Your care remains personal
Your doctor leads. The product follows.
NOVATHERIS does not diagnose, prescribe or sell prescription medicines directly to the public. Do not use this website to select a therapy, calculate a dose, change treatment or decide whether a medicine is safe for you.
For registered medical practitioners
Professional access begins with verification.
Apply for a NOVATHERIS professional profile. Access to information or supply remains subject to verification, product-specific legal status, the Medicines and Related Substances Act, valid prescribing and dispensing authority, and any applicable SAHPRA authorisation.
Clear answers
Frequently asked.
A sophisticated clinical brand should be precise about what it is—and equally precise about what it is not.
Can a patient order NOVATHERIS directly?
No. NOVATHERIS does not offer direct-to-public ordering. Any prescription product must move through a lawful professional supply and dispensing channel.
Does NOVATHERIS recommend a peptide or NAD protocol?
No. Treatment selection, route, dose, monitoring and duration require product-specific information and an individual clinical decision by an appropriately authorised practitioner.
Are all peptide products registered medicines?
No. Regulatory status differs by active substance, presentation, indication and supply route. An unregistered medicine may not be sold merely because a doctor writes a prescription; any required SAHPRA authorisation must already be in place.
What does professional approval mean?
It means NOVATHERIS has verified selected professional details for controlled communication. It is not HPCSA accreditation, a dispensing licence, SAHPRA approval, endorsement of a product or permission to practise outside your registered scope.
How do I report a concern?
Use the product label’s QR code or visit novatheris.co.za/report. Keep the product, packaging, batch or lot number and expiry details available. Urgent medical concerns must go to a treating practitioner or emergency service.